参考文献/References:
[1] 田瑞,周芸.慢性肾脏病概念及分期诊断标准的演变和现状[J].国际移植与血液净化杂志, 2018,16(1):1-4. TIAN Rui, ZHOU Yun. Chronic kidney disease: difinition, evaluation and classification [J]. International Journal of Transplantation and Hemopurification, 2018, 16 (1) : 1-4.
[2] JHA V, GARCIA-GARCIA G, ISEKJ K,et a1.Chronic kidney disease: global dimension and perspectives[J]. Lancet, 2013, 382(9888): 260-272.
[3] 王旭,马清.不同公式计算的估算肾小球滤过率对老年慢性肾脏病预后的分析[J].中华老年多器官疾病杂志,2019,18(6):405-409. WANG Xu, MA Qing. Prognostic analysis of chronic kidney disease in the elderly with estimated glomerular filtration rate by various equations [J]. Chinese Journal of Multiple Organ Diseases in the Elderly, 2019,18(6):405-409.
[4] MISCHAK H, DELLES C, VLAHOU A, et al. Proteomic biomarkers in kidney disease: issues in development and implementation[J]. Nature Reviews Nephrology, 2015, 11(4):221-232.
[5] HU Mingchang,SHI Mingjun, ZHANG Jianning,et a1. Renal production, uptake,and bandling of circulating alpha-Klotho[J]. Journal of the American Society of Nephrology, 2016, 27 (1): 79-90.
[6] 杨雄, 尹爱萍. 慢性肾脏病不同分期患者血清多项骨代谢指标变化与成纤维细胞生长因子23的相关性分析[J]. 现代检验医学杂志,2019,34(4):58-61, 66. YANG Xiong, YIN Aiping. Analysis of the correlation between serum bone metabolism and fibroblast growth factor 23 in patients with chronic kidney disease at different stages[J]. Journal of Modern Laboratory Medicine, 2019, 34(4): 58-61,66.
[7] 李安平, 刘洪梅, 李婵, 等.血清ProGRP和HE4在慢性肾脏病患者中的临床意义[J].标记免疫分析与临床, 2017,24(10):1123-1125. LI Anping, LIU Hongmei, LI Chan, et al. The clinical significance of serum proGRP and HE4 in patients with chronic kidney disease [J]. Labeled Immunoassays and Clinical Medicine, 2017,24(10):1123-1125.
[8] RISCH L, LHOTTA K, MEIER D, et al. The serum uromodulin level is associated with kidney function[J]. Clinical Chemistry and Laboratory Medicine, 2014, 52(12) : 1755-1761.
[9] 李莎莎,叶建明,董晓红,等.血清Klotho水平对慢性肾脏病患者肾功能进展的预测价值[J].临床检验杂志, 2017,35(9):666-670. LI Shasha, YE Jianming, DONG Xiaohong, et al. Predictive value of serum Klotho level for progression of renal function in patients with chronic kidney disease [J]. Chinese Journal of Clinical Laboratory Science, 2017,35(9):666-670.
[10] 张博旦,李寒,孙倩美.不同肾小球滤过率评估公式在老年人中的适用性分析[J].中华老年多器官疾病杂志,2018,17(4):313-317. ZHANG Bodan, LI Han, SUN Qianmei. Applicability analyses for glomerular filtration rate evaluation formula in the elderly [J]. Chinese Journal of Multiple Organ Diseases in the Elderly, 2018,17(4):313-317.
[11] SHARDLOW A, MCINTYRE N J, FLUCK R J, et al. Chronic kidney disease in primary care: outcomes after five years in a prospective cohort study[J]. PLoS Med, 2016, 13(9): e1002128.
[12] 尤瑞莲,徐鲁斌,陈丽萌.尿调节素及UMOD基因与慢性肾病的相关性研究进展[J].基础医学与临床, 2020, 40(4) : 557-561. YOU Ruilian, XU Lubin, CHEN Limeng. Advances in the correlation of uromodulin and UMOD gene with chronic kidney disease [J]. Basic & Clinical Medicine, 2020, 40(4) : 557-561.
[13] 卢美红, 杨春兰, 景蓉蓉, 等.血清人附睾蛋白4表达与慢性肾脏病的相关性研究[J].现代检验医学杂志, 2017, 32(2): 75-77,81. LU Meihong, YANG Chunlan, JING Rongrong, et al. Study on association with expression in patients with chronic kidney disease [J]. Journal of Modern Laboratory Medicine, 2017, 32(2): 75-77,81.
[14] 杨晓霞,柏明,刘丽敏,等.慢性肾脏病患者血清人附睾蛋白4与疾病进展的关系[J].肾脏病与透析肾移植杂志,2016,25(2):128-133. YANG Xiaoxia, BO Ming, LIU Limin, et al. Significance of serum human epididymis protein 4 levels in patients with chronic kidney disease [J]. Chinese Journal of Nephrology, Dialysis & Transplantation, 2016,25(2):128-133.
[15] QIAN Jing, ZHONG Jianyong, YAN Minhua, et al. Circulating α-Klotho is related to plasma aldosterone and its follow-up change predicts CKD progression [J]. Kidney Blood Press Res, 2018, 43(3): 836-846.
[16] 李莎莎,郁丽霞,何敖林,等.分泌型Klotho作为慢性肾脏病患者血清学标志物的可行性研究进展[J].中华肾脏病杂志, 2018, 34(12):956-960. LI Shasha, YU Lixia, HE Aolin, et al. Perspectives of soluble Klotho as a potential biomarker for patients with chronic kidney disease [J]. Chinese Journal of Nephrology, 2018, 34(12):956-960.
[17] LIU Qifeng,YE Jianming,YU Lixia,et al. Klotho mitigates cyclosporine A (CsA)-induced epithelial- mesenchymal transition (EMT) and renal fibrosis in rats.[J]. International Urology and Nephrology, 2017,49(2):345-352.
[18] BAILIE C, KILNER J, MAXWELL A P, et al. Development of next generation sequencing panel for UMOD and association with kidney disease[J]. PLoS One, 2017, 12(6):e0178321.
[19] DEVUYST O, OLINGER E, RAMPOLDI L, et al. Uromodulin: From physiology to rare and complex kidney disorders(Review)[J]. Nature Reviews Nephrology, 2017, 13(9):525-544.
[20] LEBLEU V S,TENG Y,O’CONNELL J T,et al . Identification of human epididymis protein-4 as a fibroblast-derived mediator of fibrosis(Article)[J]. Nature Medicine, 2013, 19(2):227-231.